GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [PSA] TRIUMPH is not what most of this community thinks it is — 56 comments in the full submission. View in context.
1k
c/retatrutide·submitted 1 year ago by u/kofi_balogun

[PSA] TRIUMPH is not what most of this community thinks it is

Discussionbranch of 8 comments

Something I noticed reading old threads that I have not seen said out loud. The advice on TRIUMPH in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with…

Read the full submission and all 56 comments →

This branch

8 comments, started 1 year ago
u/ledger_modMOD117 points·1 year ago

Flair changed to match the content. Read the sidebar before posting next time and we are square.

replysharereportpermalink
u/janek_ferrari69 points·1 year ago

retatrutide is not approved anywhere for human use, posts must not read as instructions

replysharereportpermalink
u/yannick_barros72 points·1 year ago

Sceptical. If this were true we would see it reflected in the data and we do not.

replysharereportpermalink
u/lina_bruun25 points·1 year ago

Are you quoting phase 2 or is there phase 3 data now?

replysharereportpermalink
u/incretin_ivypharmacology15 points·1 year ago

research use only, handling and analysis, not protocols

replysharereportpermalink
u/kavya_kravchenko30 points·1 year ago

Respectfully this is a sample of one presented as a finding.

replysharereportpermalink
u/zeynep_mbeki55 points·1 year ago

research use only, handling and analysis, not protocols

replysharereportpermalink
u/renzo_yildiz27 points·1 year ago

Yeah, phase 2 retatrutide is interesting but it is not comparable to phase 3 compounds.

replysharereportpermalink

← back to the whole thread

About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
More in c/retatrutide
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/reta_and_regretu/trialwatch_theou/incretin_ivyu/ledger_mod
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →